ArticleDrug design, development and therapy2019

Efficacy of a recombinant single-chain fragment variable region, VasSF, as a new drug for vasculitis [Corrigendum].

Y Kameoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.